Document:

Exhibit 10.1.3

                             Form of Class B Warrant

THIS WARRANT AND THE COMMON  SHARES  ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  THIS WARRANT
AND THE COMMON  SHARES  ISSUABLE  UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,
OFFERED  FOR SALE,  PLEDGED  OR  HYPOTHECATED  IN THE  ABSENCE  OF AN  EFFECTIVE
REGISTRATION  STATEMENT  UNDER  SAID ACT OR AN  OPINION  OF  COUNSEL  REASONABLY
SATISFACTORY TO VOIP, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

                         Right to Purchase  ________  shares of Common  Stock
                         of VoIP, Inc.(subject to adjustment as provided herein)

                         COMMON STOCK PURCHASE B WARRANT

No. 2004-NOV-001                                  Issue Date: November ___, 2004

     VoIP,  INC., a corporation  organized  under the laws of the State of Texas
(the    "Company"),    hereby    certifies    that,    for    value    received,
____________________________ or its assigns (the "Holder"), is entitled, subject
to the terms set forth below,  to purchase from the Company at any time from the
date an effective  registration  statement  which  includes  the Warrant  Shares
issuable  upon  exercise  of the B Warrants is  declared  effective  through the
thirtieth  (30th)  day  of  such  effectiveness(the  "Expiration  Date"),  up to
_________ fully paid and nonassessable shares of the common stock of the Company
(the "Common  Stock"),  $.001 par value per share at an exercise price of $1.20.
The  aforedescribed  purchase price per share,  as adjusted from time to time as
herein provided,  is referred to herein as the "Purchase  Price." The number and
character of such shares of Common  Stock and the Purchase  Price are subject to
adjustment as provided herein. The Company may reduce the Purchase Price without
the  consent of the Holder.  Capitalized  terms used and not  otherwise  defined
herein shall have the meanings set forth in that certain Subscription  Agreement
(the "Subscription Agreement"),  dated as of November ___, 2004, entered into by
the Company and the Holder.

     As used herein the following terms,  unless the context otherwise requires,
have the following respective meanings:

     (a) The term "Company" shall include VoIP,  Inc. and any corporation  which
shall succeed or assume the obligations of VoIP, Inc. hereunder.

     (b) The term "Common Stock" includes (a) the Company's Common Stock,  $.001
par value per share,  as authorized on the date of the  Subscription  Agreement,
and (b) any other  securities  into  which or for  which  any of the  securities
described  in  (a)  may  be  converted  or  exchanged  pursuant  to  a  plan  of
recapitalization, reorganization, merger, sale of assets or otherwise.

     (c) The term  "Other  Securities"  refers to any stock  (other  than Common
Stock) and other  securities  of the Company or any other person  (corporate  or
otherwise)  which the holder of the  Warrant at any time  shall be  entitled  to
receive,  or shall have received,  on the exercise of the Warrant, in lieu of or

<PAGE>

in  addition  to Common  Stock,  or which at any time shall be issuable or shall
have been  issued in exchange  for or in  replacement  of Common  Stock or Other
Securities pursuant to Section 4 or otherwise.

     1.   Exercise of Warrant.

     1.1. Number of Shares Issuable upon Exercise. From and after the Issue Date
through and including the  Expiration  Date, the Holder hereof shall be entitled
to receive,  upon exercise of this Warrant in whole in accordance with the terms
of subsection  1.2 or upon  exercise of this Warrant in part in accordance  with
subsection  1.3,  shares of Common Stock of the Company,  subject to  adjustment
pursuant to Section 4.

     1.2.  Full  Exercise.  This  Warrant may be exercised in full by the Holder
hereof by delivery of an original or facsimile copy of the form of  subscription
attached as Exhibit A hereto  (the  "Subscription  Form") duly  executed by such
Holder and surrender of the original  Warrant within seven (7) days of exercise,
to the Company at its principal office or at the office of its Warrant Agent (as
provided  hereinafter),  accompanied  by payment,  in cash,  wire transfer or by
certified or official  bank check  payable to the order of the  Company,  in the
amount  obtained by  multiplying  the number of shares of Common Stock for which
this Warrant is then exercisable by the Purchase Price then in effect.

     1.3. Partial Exercise. This Warrant may be exercised in part (but not for a
fractional  share) by  surrender  of this Warrant in the manner and at the place
provided in subsection  1.2 except that the amount payable by the Holder on such
partial  exercise shall be the amount  obtained by multiplying (a) the number of
whole shares of Common Stock designated by the Holder in the  Subscription  Form
by (b) the  Purchase  Price then in effect.  On any such partial  exercise,  the
Company,  at its expense,  will forthwith issue and deliver to or upon the order
of the  Holder  hereof a new  Warrant of like  tenor,  in the name of the Holder
hereof or as such Holder (upon payment by such Holder of any applicable transfer
taxes) may  request,  the whole  number of shares of Common Stock for which such
Warrant may still be exercised.

     1.4. Fair Market Value.  Fair Market Value of a share of Common Stock as of
a particular date (the "Determination Date") shall mean:

     (a) If the Company's  Common Stock is traded on an exchange or is quoted on
the  National  Association  of  Securities  Dealers,  Inc.  Automated  Quotation
("NASDAQ"),  National Market System,  the NASDAQ SmallCap Market or the American
Stock Exchange, LLC, then the closing or last sale price, respectively, reported
for the last business day immediately preceding the Determination Date;

     (b) If the  Company's  Common  Stock is not traded on an exchange or on the
NASDAQ National Market System,  the NASDAQ SmallCap Market or the American Stock
Exchange,  Inc., but is traded in the over-the-counter  market, then the average
of the closing bid and ask prices reported for the last business day immediately
preceding the Determination Date;

     (c) Except as provided in clause (d) below,  if the Company's  Common Stock
is not  publicly  traded,  then as the Holder and the Company  agree,  or in the
absence of such an agreement,  by arbitration in accordance  with the rules then
standing of the American Arbitration Association,  before a single arbitrator to
be chosen from a panel of persons qualified by education and training to pass on
the matter to be decided; or

<PAGE>

     (d) If the Determination Date is the date of a liquidation,  dissolution or
winding up, or any event deemed to be a  liquidation,  dissolution or winding up
pursuant to the Company's  charter,  then all amounts to be payable per share to
holders  of the  Common  Stock  pursuant  to the  charter  in the  event of such
liquidation, dissolution or winding up, plus all other amounts to be payable per
share in respect of the Common Stock in liquidation under the charter,  assuming
for the  purposes of this clause (d) that all of the shares of Common Stock then
issuable  upon  exercise  of  all  of  the  Warrants  are   outstanding  at  the
Determination Date.

     1.5. Company Acknowledgment.  The Company will, at the time of the exercise
of the Warrant, upon the request of the Holder hereof acknowledge in writing its
continuing  obligation  to afford to such Holder any rights to which such Holder
shall  continue  to be  entitled  after such  exercise  in  accordance  with the
provisions of this  Warrant.  If the Holder shall fail to make any such request,
such failure shall not affect the continuing obligation of the Company to afford
to such Holder any such rights.

     1.6. Trustee for Warrant Holders. In the event that a bank or trust company
shall have been appointed as trustee for the Holder of the Warrants  pursuant to
Subsection  3.2, such bank or trust company shall have all the powers and duties
of a warrant agent (as hereinafter  described) and shall accept, in its own name
for the  account of the  Company  or such  successor  person as may be  entitled
thereto, all amounts otherwise payable to the Company or such successor,  as the
case may be, on exercise of this Warrant pursuant to this Section 1.

     1.7. Delivery of Stock Certificates,  etc. on Exercise.  The Company agrees
that the shares of Common Stock purchased upon exercise of this Warrant shall be
deemed to be issued to the Holder  hereof as the record  owner of such shares as
of the close of  business  on the date on which  this  Warrant  shall  have been
surrendered  and  payment  made  for  such  shares  as  aforesaid.  As  soon  as
practicable  after the exercise of this  Warrant in full or in part,  and in any
event within five (5) days thereafter, the Company at its expense (including the
payment by it of any applicable issue taxes) will cause to be issued in the name
of and delivered to the Holder  hereof,  or as such Holder (upon payment by such
Holder  of  any  applicable  transfer  taxes)  may  direct  in  compliance  with
applicable securities laws, a certificate or certificates for the number of duly
and validly  issued,  fully paid and  nonassessable  shares of Common  Stock (or
Other Securities) to which such Holder shall be entitled on such exercise, plus,
in lieu of any  fractional  share  to  which  such  Holder  would  otherwise  be
entitled,  cash equal to such fraction  multiplied by the then Fair Market Value
of one full  share of  Common  Stock,  together  with any  other  stock or other
securities and property  (including cash, where applicable) to which such Holder
is entitled upon such exercise pursuant to Section 1 or otherwise.

     2.   [RESERVED].

     3.   Adjustment for Reorganization, Consolidation, Merger, etc.

     3.1.  Reorganization,  Consolidation,  Merger,  etc. In case at any time or
from  time  to  time,  the  Company  shall  (a)  effect  a  reorganization,  (b)
consolidate  with  or  merge  into  any  other  person  or (c)  transfer  all or
substantially all of its properties or assets to any other person under any plan
or arrangement  contemplating the dissolution of the Company, then, in each such
case,  as a condition  to the  consummation  of such a  transaction,  proper and
adequate  provision  shall be made by the  Company  whereby  the  Holder of this
Warrant,  on the exercise hereof as provided in Section 1, at any time after the
consummation of such  reorganization,  consolidation  or merger or the effective

<PAGE>

date of such  dissolution,  as the case may be,  shall  receive,  in lieu of the
Common  Stock (or Other  Securities)  issuable  on such  exercise  prior to such
consummation or such effective date, the stock and other securities and property
(including  cash) to which  such  Holder  would  have  been  entitled  upon such
consummation or in connection with such dissolution, as the case may be, if such
Holder had so exercised this Warrant,  immediately prior thereto, all subject to
further adjustment thereafter as provided in Section 4.

     3.2. Dissolution.  In the event of any dissolution of the Company following
the  transfer  of all or  substantially  all of its  properties  or assets,  the
Company, prior to such dissolution,  shall at its expense deliver or cause to be
delivered the stock and other  securities and property  (including  cash,  where
applicable) receivable by the Holder of the Warrants after the effective date of
such  dissolution  pursuant  to this  Section  3 to a bank or trust  company  (a
"Trustee")  having its  principal  office in New York,  NY, as  trustee  for the
Holder of the Warrants.

     3.3. Continuation of Terms. Upon any reorganization,  consolidation, merger
or transfer (and any  dissolution  following  any transfer)  referred to in this
Section 3, this  Warrant  shall  continue in full force and effect and the terms
hereof shall be applicable to the Other  Securities  and property  receivable on
the  exercise of this Warrant  after the  consummation  of such  reorganization,
consolidation or merger or the effective date of dissolution  following any such
transfer,  as the case may be, and shall be binding upon the issuer of any Other
Securities,  including,  in the case of any such transfer,  the person acquiring
all or substantially all of the properties or assets of the Company,  whether or
not such  person  shall  have  expressly  assumed  the terms of this  Warrant as
provided in Section 4. In the event this Warrant does not continue in full force
and effect after the  consummation of the transaction  described in this Section
3, then only in such event will the Company's securities and property (including
cash, where applicable) receivable by the Holder of the Warrants be delivered to
the Trustee as contemplated by Section 3.2.

     3.4 Share  Issuance.  Until the  expiration  of the  Exclusion  Period  (as
defined in the  Subscription  Agreement),  if the Company shall issue any Common
Stock  except  for  the  Excepted  Issuances  (as  defined  in the  Subscription
Agreement),  prior to the complete  exercise of this Warrant for a consideration
less than the Purchase  Price that would be in effect at the time of such issue,
then, and thereafter successively upon each such issue, the Purchase Price shall
be reduced to such other lower issue price. For purposes of this adjustment, the
issuance of any security or debt instrument of the Company carrying the right to
convert such  security or debt  instrument  into Common Stock or of any warrant,
right or option to purchase  Common Stock shall result in an  adjustment  to the
Purchase  Price  upon  the  issuance  of  the  above-described   security,  debt
instrument,  warrant,  right,  or option.  The  reduction of the Purchase  Price
described  in this  Section 3.4 is in addition to the other rights of the Holder
described in the Subscription Agreement.

     4.  Extraordinary  Events  Regarding  Common  Stock.  In the event that the
Company shall (a) issue  additional  shares of the Common Stock as a dividend or
other  distribution on outstanding  Common Stock,  (b) subdivide its outstanding
shares of Common  Stock,  or (c)  combine its  outstanding  shares of the Common
Stock into a smaller  number of shares of the Common  Stock,  then, in each such
event,  the Purchase  Price  shall,  simultaneously  with the  happening of such
event,  be adjusted by multiplying  the then Purchase  Price by a fraction,  the
numerator  of which  shall be the number of shares of Common  Stock  outstanding

<PAGE>

immediately prior to such event and the denominator of which shall be the number
of shares of Common  Stock  outstanding  immediately  after such event,  and the
product so obtained shall  thereafter be the Purchase Price then in effect.  The
Purchase Price, as so adjusted,  shall be readjusted in the same manner upon the
happening of any successive  event or events described herein in this Section 4.
The  number of shares of Common  Stock  that the  Holder of this  Warrant  shall
thereafter,  on the  exercise  hereof as  provided  in Section 1, be entitled to
receive shall be adjusted to a number  determined by  multiplying  the number of
shares of Common  Stock that would  otherwise  (but for the  provisions  of this
Section 4) be issuable on such exercise by a fraction of which (a) the numerator
is the  Purchase  Price that would  otherwise  (but for the  provisions  of this
Section 4) be in effect, and (b) the denominator is the Purchase Price in effect
on the date of such exercise.

     5.  Certificate  as to  Adjustments.  In  each  case of any  adjustment  or
readjustment in the shares of Common Stock (or Other Securities) issuable on the
exercise of the  Warrants,  the Company at its expense will  promptly  cause its
Chief Financial Officer or other appropriate designee to compute such adjustment
or  readjustment  in  accordance  with the terms of the  Warrant  and  prepare a
certificate  setting forth such adjustment or readjustment and showing in detail
the facts upon which such  adjustment  or  readjustment  is based,  including  a
statement of (a) the consideration received or receivable by the Company for any
additional shares of Common Stock (or Other Securities) issued or sold or deemed
to have been issued or sold,  (b) the number of shares of Common Stock (or Other
Securities) outstanding or deemed to be outstanding,  and (c) the Purchase Price
and the number of shares of Common  Stock to be received  upon  exercise of this
Warrant,  in effect  immediately prior to such adjustment or readjustment and as
adjusted or readjusted as provided in this Warrant.  The Company will  forthwith
mail a copy of each  such  certificate  to the  Holder  of the  Warrant  and any
Warrant Agent of the Company (appointed pursuant to Section 11 hereof).

     6. Reservation of Stock,  etc.  Issuable on Exercise of Warrant;  Financial
Statements. The Company will at all times reserve and keep available, solely for
issuance  and  delivery on the  exercise of the  Warrants,  all shares of Common
Stock (or Other  Securities)  from time to time  issuable on the exercise of the
Warrant.  This  Warrant  entitles  the Holder  hereof to  receive  copies of all
financial and other information distributed or required to be distributed to the
holders of the Company's Common Stock.

     7. Assignment;  Exchange of Warrant.  Subject to compliance with applicable
securities  laws,  this  Warrant,  and  the  rights  evidenced  hereby,  may  be
transferred by any registered holder hereof (a  "Transferor").  On the surrender
for exchange of this Warrant,  with the Transferor's  endorsement in the form of
Exhibit B attached hereto (the "Transferor  Endorsement Form") and together with
an opinion of counsel  reasonably  satisfactory to the Company that the transfer
of this Warrant will be in  compliance  with  applicable  securities  laws,  the
Company at its expense,  twice,  only, but with payment by the Transferor of any
applicable  transfer  taxes,  will  issue and  deliver to or on the order of the
Transferor  thereof a new Warrant or Warrants of like tenor,  in the name of the
Transferor  and/or the  transferee(s)  specified in such Transferor  Endorsement
Form  (each a  "Transferee"),  calling  in the  aggregate  on the  face or faces
thereof for the number of shares of Common Stock called for on the face or faces
of the Warrant so surrendered by the Transferor.  No such transfers shall result
in a public distribution of the Warrant.

     8. Replacement of Warrant. On receipt of evidence  reasonably  satisfactory
to the Company of the loss,  theft,  destruction  or  mutilation of this Warrant
and, in the case of any such loss,  theft or  destruction  of this  Warrant,  on
delivery of an indemnity agreement or security  reasonably  satisfactory in form
and amount to the Company or, in the case of any such  mutilation,  on surrender
and cancellation of this Warrant,  the Company at its expense,  twice only, will
execute and deliver, in lieu thereof, a new Warrant of like tenor.

<PAGE>

     9. Registration Rights. The Holder of this Warrant has been granted certain
registration  rights by the Company.  These registration rights are set forth in
the  Subscription  Agreement.  The  terms  of  the  Subscription  Agreement  are
incorporated herein by this reference. Upon the occurrence of a Non-Registration
Event, or in the event the Company is unable to issue Common Stock upon exercise
of this Warrant that has been registered in a Registration  Statement  described
in Section 11 of the Subscription  Agreement,  within the time periods described
in the Subscription  Agreement,  which Registration  Statement must be effective
for the  periods  set forth in the  Subscription  Agreement,  then upon  written
demand made by the Holder,  the Company will pay to the Holder of this  Warrant,
in lieu of  delivering  Common  Stock,  a sum equal to the closing  price of the
Company's Common Stock on the principal market or exchange upon which the Common
Stock is listed for trading on the trading date  immediately  preceding the date
notice is given by the Holder, less the Purchase Price, for each share of Common
Stock designated in such notice from the Holder.

     10.  Maximum  Exercise.  The Holder shall not be entitled to exercise  this
Warrant on an exercise date in  connection  with that number of shares of Common
Stock  which would be in excess of the sum of (i) the number of shares of Common
Stock  beneficially  owned by the Holder and its affiliates on an exercise date,
and (ii) the number of shares of Common Stock issuable upon the exercise of this
Warrant with respect to which the determination of this limitation is being made
on an exercise  date,  which would result in beneficial  ownership by the Holder
and its affiliates of more than 9.99% of the outstanding  shares of Common Stock
on such date. For the purposes of the immediately preceding sentence, beneficial
ownership shall be determined in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended,  and Regulation 13d-3  thereunder.  Subject to
the  foregoing,  the Holder  shall not be limited to aggregate  exercises  which
would result in the issuance of more than 9.99%.  The  restriction  described in
this  paragraph  may be revoked upon  sixty-one  (61) days prior notice from the
Holder to the  Company.  The  Holder  may  allocate  which of the  equity of the
Company deemed  beneficially  owned by the  Subscriber  shall be included in the
9.99%  amount  described  above and which shall be allocated to the excess above
9.99%.

     11. Warrant Agent.  The Company may, by written notice to the Holder of the
Warrant,  appoint an agent (a "Warrant Agent") for the purpose of issuing Common
Stock (or Other  Securities) on the exercise of this Warrant pursuant to Section
1,  exchanging  this Warrant  pursuant to Section 7, and replacing  this Warrant
pursuant  to  Section  8,  or any of the  foregoing,  and  thereafter  any  such
issuance,  exchange or  replacement,  as the case may be,  shall be made at such
office by such Warrant Agent.

     12. Transfer on the Company's  Books.  Until this Warrant is transferred on
the books of the Company,  the Company may treat the registered holder hereof as
the absolute  owner hereof for all purposes,  notwithstanding  any notice to the
contrary.

     13. Notices. All notices, demands, requests, consents, approvals, and other
communications  required or permitted  hereunder shall be in writing and, unless
otherwise  specified herein,  shall be (i) personally served,  (ii) deposited in
the mail,  registered or certified,  return receipt requested,  postage prepaid,
(iii) delivered by reputable air courier service with charges  prepaid,  or (iv)
transmitted by hand  delivery,  telegram,  or facsimile,  addressed as set forth
below or to such other address as such party shall have  specified most recently
by written notice. Any notice or other communication required or permitted to be

<PAGE>

given hereunder shall be deemed  effective (a) upon hand delivery or delivery by
facsimile,  with accurate confirmation  generated by the transmitting  facsimile
machine,  at the address or number  designated below (if delivered on a business
day during normal  business  hours where such notice is to be received),  or the
first  business  day  following  such  delivery  (if  delivered  other than on a
business day during normal  business  hours where such notice is to be received)
or (b) on the  second  business  day  following  the date of  mailing by express
courier  service,  fully  prepaid,  addressed  to such  address,  or upon actual
receipt of such  mailing,  whichever  shall first occur.  The addresses for such
communications shall be: (i) if to the Company to VoIP, Inc., 12330 SW53 Street,
Suite  712,  Cooper  City  Florida  33330,  Attn:  Steven  Ivester,   President,
telecopier:    (954)    434-2877with    a   copy   by   telecopier    only   to:
______________________________________________________, telecopier: ___________,
and (ii) if to the Holder,  to the address and  telecopier  number listed on the
first  paragraph of this Warrant,  with a copy by telecopier  only to: Grushko &
Mittman,  P.C.,  551  Fifth  Avenue,  Suite  1601,  New  York,  New York  10176,
telecopier number: (212) 697-3575.

     14. Miscellaneous. This Warrant and any term hereof may be changed, waived,
discharged  or terminated  only by an instrument in writing  signed by the party
against which  enforcement of such change,  waiver,  discharge or termination is
sought.  This Warrant  shall be construed  and enforced in  accordance  with and
governed by the laws of New York. Any dispute  relating to this Warrant shall be
adjudicated  in New York County in the State of New York.  The  headings in this
Warrant are for  purposes of  reference  only,  and shall not limit or otherwise
affect  any of the terms  hereof.  The  invalidity  or  unenforceability  of any
provision  hereof shall in no way affect the validity or  enforceability  of any
other provision.

                      [THIS SPACE INTENTIONALLY LEFT BLANK]

<PAGE>

     IN WITNESS  WHEREOF,  the Company has executed  this Warrant as of the date
first written above.

                                    VOIP, INC.

                                        By:
                                           -------------------------------------
                                      Name:
                                     Title:

Witness:

----------------------------------

<PAGE>

                                    Exhibit A

                              FORM OF SUBSCRIPTION
                   (to be signed only on exercise of Warrant)

TO:  VOIP, INC.

The  undersigned,  pursuant to the provisions set forth in the attached  Warrant
(No.____), hereby irrevocably elects to purchase (check applicable box):

___ ________  shares of the Common  Stock  covered by such  Warrant;  or ___ the
maximum number of shares of Common Stock covered by such Warrant pursuant to the
cashless exercise procedure set forth in Section 2.

The  undersigned  herewith  makes  payment of the full  purchase  price for such
shares  at  the  price  per  share  provided  for  in  such  Warrant,  which  is
$___________. Such payment takes the form of (check applicable box or boxes):

___  $__________  in  lawful  money  of  the  United  States;   and/or  ___  the
cancellation  of such portion of the attached  Warrant as is  exercisable  for a
total of _______  shares of Common  Stock (using a Fair Market Value of $_______
per share for purposes of this calculation); and/or

___ the  cancellation  of such number of shares of Common Stock as is necessary,
in accordance  with the formula set forth in Section 2, to exercise this Warrant
with  respect  to the  maximum  number of shares  of  Common  Stock  purchasable
pursuant to the cashless exercise procedure set forth in Section 2.

The undersigned  requests that the certificates for such shares be issued in the
name of, and delivered to  _____________________________________________________
whose address is
                ---------------------------------------------------------------.

The  undersigned  represents  and  warrants  that all  offers  and  sales by the
undersigned of the securities issuable upon exercise of the within Warrant shall
be made pursuant to registration of the Common Stock under the Securities Act of
1933,  as amended  (the  "Securities  Act"),  or pursuant to an  exemption  from
registration under the Securities Act.

Dated:___________________
                                       (Signature must conform to name of holder
                                        as specified on the face of the Warrant)

                                       (Address)

<PAGE>

                                    Exhibit B

                         FORM OF TRANSFEROR ENDORSEMENT
                   (To be signed only on transfer of Warrant)

     For value received,  the undersigned hereby sells,  assigns,  and transfers
unto the  person(s)  named  below  under  the  heading  "Transferees"  the right
represented  by the within  Warrant to  purchase  the  percentage  and number of
shares  of  Common  Stock of VOIP,  INC.  to which the  within  Warrant  relates
specified under the headings "Percentage  Transferred" and "Number Transferred,"
respectively,  opposite the name(s) of such  person(s)  and  appoints  each such
person Attorney to transfer its respective right on the books of VOIP, INC. with
full power of substitution in the premises.

--------------------------------------------------------------------------------
Transferees                  Percentage Transferred           Number Transferred
-----------                  ----------------------           ------------------
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Dated:
      -----,---------               --------------------------------------------
                                    --------------------------------------------
                                    (Signature must conform to name of holder as
                                     specified on the face of the warrant)

Signed in the presence of:

----------------------------       ---------------------------------------------
        (Name)                     ---------------------------------------------
                                                    (address)

ACCEPTED AND AGREED:               ---------------------------------------------
[TRANSFEREE]                       ---------------------------------------------
                                    (address)

----------------------------
         (Name)EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "1933 ACT"), NOR REGISTERED
UNDER ANY STATE SECURITIES LAW, AND ARE "RESTRICTED SECURITIES" AS THAT TERM
IS DEFINED IN RULE 144 UNDER THE 1933 ACT.  THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE 1933 ACT, THE AVAILABILITY OF WHICH IS TO BE
ESTABLISHED TO THE SATISFACTION OF THE COMPANY.

      This EXCLUSIVE LICENSING AGREEMENT is made this 5th day of November,
2004, by and among Aquentium, Inc., a Delaware corporation, (the "Issuer" or
the "Company"), and Theodore Thomas Gerard Ciotti ("TC"), a citizen of the
United States of America and resident of the State of Florida.

      In consideration of the mutual promises, covenants, and representations
contained herein, and other good and valuable consideration, THE PARTIES
HERETO AGREE AS FOLLOWS:

1.    EXCHANGE OF SECURITIES
      ----------------------
      Subject to the terms and conditions of this Agreement, the Issuer agrees
to issue to TC, two hundred thousand (200,000) restricted shares, as a
non-refundable exchange for the exclusive worldwide manufacturing and
marketing rights of a patent pending containerized habitable structure as
granted by the United States Patent & Trademark Office (USPTO); United States
Patent Application 10/284,748 and deviations thereof. Should the patent not be
granted, then Issuer has the right to cancel the two hundred thousand
(200,000) shares issued to TC.
     TC grants to Issuer:
      a.    Exclusive global licensing rights for current and future
            inventions, evolutions, concepts, ideas, materials, plans, leads
            and contacts as pertaining to the above pending patent.
      b.    Exclusive global licensing rights for use of products' trade names
            as pertaining to the above pending patent.
      c.    Exclusive global licensing rights for use of management, marketing
            systems, concepts, plans and materials as pertaining to the above
            pending patent.
      d.    Exclusive global licensing rights for use of all trademarks and
            copyrights as pertaining to the above pending patent.
      e.    Exclusive global licensing rights for use of Website URL and
            content as pertaining to the above pending patent.
      f.    All future developments of products, trademarks, copyrights,
            patents and other intellectual property pertaining to the original
            pending patent; of which, TC shall be the exclusive owner with an
            automatic and simultaneous exclusive global licensing right for
            use granted to Issuer. Patents and certain other intellectual
            property shall be negotiated for fee and use on a case by case
            basis.

      Upon completion of this transaction, the Issuer will form a subsidiary
company ("New Company") with a name that is mutually agreed by both parties.
This subsidiary will be the entity that markets and manufactures under this
licensing agreement.

2.    ROYALTY DISTRIBUTIONS
      ---------------------
      Issuer represents and warrants to TC:
      a.    To make Royalty payments according to the schedule in 2-h below.

Issuer's Initials                    Page 1 of 8                 TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

      b.    Royalties are paid on all units produced excluding any units that
            are specifically designated, properly marked and used as samples,
            R & D, prototypes or donations.
      c.    Royalty payments are based on the following lifetime production
            schedule and production totals are cumulative over the lifetime
            production of the units:
                  Royalty per Unit             Lifetime Unit Production
                  --------------------------------------------------------
                       $1,000                          1 to 250,000
                          750                    250,001 to 500,000
                          500                          over 500,000
      d.    Royalties are due and payable in US dollars, for the life of the
            license agreement.
      e.    Units are described as items covered under this agreement include
            United States Patent Application number: 10/284,748, Title:
            Containerized habitable structures, Description: Patent Pending of
            an expandable ISO containerized systems and structures for
            emergency, disaster relief or permanent applications world wide,
            and U.S. Provisional Patent Application number 60/236,188;
            including all foreign patents that are or will be filled; and any
            derivatives thereof.
      f.    The right to audit the company's relevant books and records and to
            physically inspect any facility of the company; including work
            papers, through the use of independent auditors or personally at
            any pre-arranged time. If the royalties actually reported for the
            period of the audit are under paid by five (5%) percent of the
            royalties determined payable by the audit, the company shall pay
            for the entire costs of performing the audit including the
            accountant's professional fees plus unpaid royalties with maximum
            interest.
      g.    Annual accounting (October 1 to September 30) shall be completed,
            unless waived in writing by both parties.
      h.    Schedule of Royalty Payments:
                  Production Period                Payment Date
                  ----------------------------------------------
                  January 1 to March 31            April 30
                  April 1 to June 30               July 31
                  July 1 to September 30           October 31
                  October 1 to December 31         January 31
      i.    Company shall keep royalty related documents and records for three
            (3) years after payment, for future audits, if needed, including a
            master production log and distribution logs showing the unit's
            disposition (sold, donated, samples, R & D, etc.). All units shall
            have a unique serial number.
      j.    Royalty shall be fully assignable including all rights therewith
            in whole or in part.

3.    PERFORMANCE REQUIREMENTS
      -------------------------
      a.  Issuer represents and warrants to TC:
          i.   To fully comply with all the provisions as outlined in "Royalty
               Distributions" section above.
          ii.  That two (2) prototype model units will be funded within twelve
               (12) months from the date of this agreement, approximately
               thirty thousand ($30,000) US dollars each.
          iii. Using its best efforts, will raise and make available funds for
               the setup and equipping of an initial manufacturing facility to
               be located in the USA, within twenty four (24) months from the
               date of this agreement. TC to guide Issuer, as to where, and
               the amounts and timing of the required funds.
          iv.  Production minimum of thirty (30) units per quarter starting
               ninety (90) days after manufacturing facility is completed and
               all manufacturing materials and components are in place.

Issuer's Initials                    Page 2 of 8                TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

           v.  New company shall be setup within thirty (30) days of this
               agreement.
          vi.  Provide the funds as needed for operations, general,
               administrative and support of the new company.
          vii. TC shall be issued a contract with the new company upon its
               creation.
         viii. TC shall be issued a Board seat in the new company upon its
               creation.
           ix. Shall not otherwise engage or do business in the disaster
               relief housing industry as a provider of disaster housing or
               other disaster structures.
            x. Upon the failure of any of the above Performance Requirements,
               Issuer hereby:
               a.  Grants the immediate and absolute rescission of the
                   "Exclusivity" of this entire License Agreement.
               b.  To execute the reissuance of a revised license agreement
                   identical to this original license agreement with the
                   removal of the word, term or reference to this licensing
                   agreement as being "Exclusive" to be "Non-Exclusive".
               c.  TC is released from the non-compete cause in section
                   7-b-ii.
      b.    TC represents and warrants to Issuer:
            i.  To provide all contact and authorizations as needed in regards
                to the Patent Law Firm as soon as possible.
           ii.  Construct two (2) prototype model units in a timely manner
                upon Issuer providing the necessary funding.
          iii.  Setup, train and make operational a manufacturing facility in
                a timely manner, upon Issuer providing the necessary funding.
           iv.  Shall not otherwise engage or do business in the disaster
                relief housing industry as a provider of disaster housing or
                other disaster structures.
            v.  Upon the full completion and compliance of Issuer's
                Performance Requirements, in section 3-a, TC shall list Issuer
                as the co-assignee of the pending patent with the USPTO.

4.     REPRESENTATIONS AND WARRANTIES
       ------------------------------
       a.  Issuer represents and warrants to TC:
           i.   Organization
                ------------
                Issuer is a corporation duly organized, validly existing, and
           in good standing under the laws of Delaware, and has all necessary
           corporate powers to own properties and carry on a business, and is
           duly qualified to do business and is in good standing in Delaware.
           All actions taken by the Incorporators, directors and shareholders
           of Issuer have been valid and in accordance with the laws of the
           State of Delaware.

           ii.  Capital Stock
                -------------
                The authorized capital stock of Issuer consists of one hundred
           million (100,000,000) shares of which, at closing, there will be
           two hundred thousand (200,000) restricted shares issued to TC in
           exchange for the exclusive licensing rights for worldwide
           manufacturing and marketing of the pending patent containerized
           habitable structure as granted by the USPTO; United States Patent
           Application 10/284,748. All of the shareholders of Issuer have
           valid title to such shares and acquired their shares in a lawful
           transaction and in accordance with the laws of the State of
           Delaware.

           iii. Pink Sheet Listing
                -------------------
                The Company is a reporting company with the Securities &
           Exchange Commission that is current with its quarterly filings.
           The company is listed for trading on the National Quotation Bureau
           Electronic Pink Sheets with the following trading symbol: AQNM. The
           company recently filed its audited statement ending June 30, 2004
           and will be required to submit an audited statement for all future
           SEC quarterly and annual filings.

Issuer's Initials             Page 4 of 8                       TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

           iv.  Assets and Liabilities
                ----------------------
                Issuer does not have any debt, liability, or obligation of any
           nature, whether accrued, absolute, contingent, or otherwise, and
           whether due or to become due, that is not reflected on the Issuer's
           financial statement. Issuer is not aware of any pending, threatened
           or asserted claims, lawsuits or contingencies involving Issuer or
           its common stock. There is no dispute of any kind between Issuer
           and any third party, and no such dispute will exist at the closing
           of this Agreement. At closing, Issuer will be free from any and all
           liabilities, liens, claims and/or commitments. Upon the Issuer or
           the new company seeking bankruptcy, this license agreement shall
           terminate immediately and be effective on the same day as the
           initial bankruptcy filling.

           v.  Ability to Carry Out Obligations
               --------------------------------
               Issuer has the right, power, and authority to enter into and
           perform its obligations under this Agreement. The execution and
           delivery of this Agreement by Issuer and the performance by Issuer
           of its obligations hereunder will not cause, constitute, or
           conflict with or result in:
           a.  Any breach or violation or any of the provisions of or
               constitute a default under any license, indenture, mortgage,
               charter, instrument, articles of incorporation, bylaw, or other
               agreement or instrument to which Issuer or its shareholders are
               a party, or by which they may be bound, nor will any consents
               or authorizations of any party other than those hereto be
               required; or
           b.  An event that would cause Issuer to be liable to any party; or
           c.  An event that would result in the creation or imposition or any
               lien, charge or encumbrance on any asset of Issuer or upon the
               securities of Issuer to be acquired hereby.

           vi. Full Disclosure
               ---------------
               None of the representations and warranties made by the Issuer,
           or in any certificate or memorandum furnished or to be furnished by
           the Issuer, contains or will contain any untrue statement of a
           material fact, or omit any material fact the omission of which
           would be misleading.

           vii. Compliance with Laws
                --------------------
                To the best of its knowledge, Issuer has complied with, and is
           not in violation of any federal, state, or local statute, law,
           and/or regulation.

           viii. Litigation
                 ----------
                 Issuer is not (and has not been) a party to any suit, action,
           arbitration, or legal, administrative, or other proceeding, or
           pending governmental investigation. To the best knowledge of the
           Issuer, there is no basis for any such action or proceeding and no
           such action or proceeding is threatened against Issuer and Issuer
           is not subject to or in default with respect to any order, writ,
           injunction, or decree of any federal, state, local, or foreign
           court, department, agency, or instrumentality.

Issuer's Initials                 Page 4 of 8                   TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

           ix.  Conduct of Business
                -------------------
                Prior to the closing, Issuer shall conduct its business in the
           normal course, and shall not:
           a.  Sell, pledge, or assign any assets; or
           b.  Amend its Articles of Incorporation or By-Laws.

           x.  Corporate Documents
               -------------------
               Copies of each of the following documents, which are true
           complete and correct in all material respects, will be attached to
           and made a part of this Agreement:
               a.  Articles of Incorporation;
               b.  By-Laws;

           xi. Documents
               ---------
               All minutes, consents or other documents pertaining to Issuer
           to be delivered at closing shall be valid and in accordance with
           the laws of the State of Delaware.

           xii. Title
                -----
                The Shares to be issued pursuant to this Agreement will be, at
           closing, free and clear of all liens, security interests, pledges,
           charges, claims, and encumbrances, but will have a restriction from
           trading for two (2) years. None of the Shares are or will be
           subject to any voting trust or agreement. No person holds or has
           the right to receive any proxy or similar instrument with respect
           to such shares, except as provided in this Agreement, the Issuer is
           not a party to any agreement which offers or grants to any person
           the right to purchase or acquire any of the securities to be issued
           pursuant to this Agreement. There is no applicable local, state or
           federal law, rule, regulation, or decree which would, as a result
           of the issuance of the Shares, impair, restrict or delay any voting
           rights with respect to the Shares.

       b.  TC represents and warrants to Issuer the following:
           i.  Organization
               ------------
               TC is an individual with an address of 2828 Gulf Gate Drive,
           Sarasota, Florida 34231 USA.  TC is of sound mind to carry on a
           business, and is duly qualified to do business in the United
           States.

           ii. Assets
               ------
               TC represents and warrants he is exclusively licensing all
           marketing and manufacturing rights to the pending patent
           application 10/284,748, and is exclusively licensing the URL
           www.instantvillage.net. Also, all future developments of products,
           trademarks, copyrights, patents and other intellectual property
           pertaining to the original pending patent; of which, TC shall be
           the exclusive owner with an automatic and simultaneous exclusive
           global licensing right for use granted to Issuer. Patents and
           certain other intellectual property shall be negotiated for fee and
           use on a case by case basis.

           iii. Liabilities
                -----------
                TC represent and warrant that it is not aware of any pending,
           threatened or asserted claims, lawsuits or contingencies involving
           TC and the rights to manufacture and market product in reference to
           pending patent application 10/284,748. There is no dispute of any
           kind between TC and any third party, and no such dispute will exist
           at the closing of this Agreement regarding pending patent
           application 10/284,748. At closing, TC will be free from any and
           all liabilities, liens, claims and/or commitments excluding the
           pending patent's legal fees therewith. Issuer assumes all future
           fees and expenses of the pending patent as of the date of this
           agreement.

Issuer's Initials                     5 of 8                     TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

           iv.  Counsel
                -------
                TC represents and warrants that prior to closing, it has been
           represented by independent counsel.

5.     INVESTMENT INTENT
       -----------------
       TC is acquiring the Shares for his own account for purposes of
investment and without expectation, desire, or need for resale and not with
the view toward distribution, resale, subdivision, or fractionalization of the
Shares.

6.     CLOSING
       -------
       The closing of this transaction shall take place at and in a manner
mutually agreed upon by both parties.

7.     DOCUMENTS TO BE DELIVERED AT CLOSING
       ------------------------------------
       a.  By the Issuer:
           i.  Board of Directors Minutes authorizing the Acceptance and
               Compliance of this Agreement and its Terms and Conditions, per
               4-a-xi
          ii.  Board of Directors Minutes authorizing the Authorized Signer,
               per 4-a-xi
         iii.  Board of Directors Minutes authorizing the issuance of a
               certificate or certificates for the Shares to be issued
               pursuant to this Agreement, per 4-a-xi
          iv.  Most recent SEC quarterly filings and audited statements, per
               4-a-iii
           v.  Articles of Incorporation and By-Laws, per 4-a-x

        b. By TC:
           i.  Signed affidavit representing one hundred (100%) percent
               complete ownership and control of pending patent application
               10/284,748.
          ii.  Signed agreement not to compete in the disaster relief housing
               industry as a provider of disaster housing or other disaster
               structures during the currency of this agreement (See section
               3-a-x-c).

8.     EXCLUSIVE/EXCLUSIVITY
       -----------------------
       In the event that Issuer fails to fully comply with section 3-a, Issuer
shall forever lose the right to be "Exclusive". Subsequently this licensing
agreement shall have the effect of automatically striking all such "Exclusive"
references herein. No stock, fees, consultant or work contracts or the
likewise shall be affected in any way. Upon the failure of any of the above
Performance Requirements in section 3-a, Issuer hereby:
       a. Grants the immediate and absolute rescission of the "Exclusivity"
            of this entire License Agreement.
       b.   To execute the reissuance of a revised license agreement identical
            to this original license agreement with the removal of the word,
            term or reference to this licensing agreement as being "Exclusive"
            to be "Non-Exclusive".
       c.   TC is released from the non-compete cause in section 7-b-ii.

Issuer's Initials                  Page 6 of 8                   TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

9.     MISCELLANEOUS
       -------------
       a.   Captions and Headings
            ---------------------
            The Article and paragraph headings throughout this Agreement are
       for convenience and reference only, and shall in no way be deemed to
       define, limit, or add to the meaning of any provision of this
       Agreement.

       b.   No Oral Change
            --------------
            This Agreement and any provision hereof, may not be waived,
       changed, modified, or discharged orally, but only by an agreement in
       writing and signed by both parties.

       c.   Jurisdiction
            ------------
            This Agreement shall be exclusively governed by and construed in
       accordance with the laws of the State of Delaware, If any action is
       brought among the parties with respect to this Agreement or otherwise,
       by way of a claim or counterclaim, the parties agree that in any such
       action, and on all issues, the parties irrevocably waive their right to
       a trial by a jury. Exclusive jurisdiction and venue for any such action
       shall be the State Courts of Delaware. In the event suit or action is
       brought by any party under this Agreement to enforce any of its terms,
       or in any appeal there from, it is agreed that the prevailing party
       shall be entitled to reasonable attorneys fees to be fixed by the
       arbitrator, trial court, and/or appellate court.

       d.   Non Waiver
            ----------
            i.  Except as otherwise expressly provided herein, no waiver of
                any covenant, condition, or provision of this Agreement shall
                be deemed to have been made unless expressly in writing and
                signed by both parties; and/or
            ii. The failure of any party to insist in any one or more cases
                upon the performance of any of the provisions, covenants, or
                conditions of this Agreement or to exercise any option herein
                contained shall not be construed as a waiver or relinquishment
                for the future of any such provisions, covenants, or
                conditions; and/or
            iii.The acceptance of performance of anything required by this
                Agreement to be performed with knowledge of the breach or
                failure of a covenant, condition, or provision hereof shall
                not be deemed a waiver of such breach or failure; and/or
            iv. No waiver by any party of one breach by another party shall be
                construed as a waiver with respect to any other or subsequent
                breach.

       e.   Time of Essence
            ---------------
            Time is of the essence of this Agreement and of each and every
       provision hereof.

       f.   Assignment
            ----------
            TC reserves the right to assign this agreement at TC's sole
       discretion.

       g.   Entire Agreement
            ----------------
            This Agreement contains the entire Agreement and understanding
       between the parties hereto, and supersedes all prior agreements and
       understandings.

       h.   Counterparts and Copies
            -----------------------
            This Agreement may be executed simultaneously in one or more
       counterparts, each of which shall be deemed an original, but all of
       which together shall constitute one and the same instrument. Copies
       and/or facsimiles shall have the same effect as the original.

Issuer's Initials                      Page 7 of 8              TC's Initials

<PAGE>

EXCLUSIVE LICENSING AGREEMENT OF US PATENT APPLICATION 10/284,748
------------------------------------------------------------------

              Between Aquentium, Inc. And Mr. Ciotti

       i.  Term and Termination
           --------------------
           This Agreement expires simultaneously with the expiration of the
       herein referenced pending patent or any extension or deviation thereof,
       whichever is the longest. This Agreement may be mutually terminated at
       any time with a six (6) month written notice that is signed and
       accepted by both parties. If Issuer initiates the termination, the
       stock restriction shall be lifted.

       j.  Notices
           -------
           All notices requests, demands, and other communications under this
       Agreement shall be in writing and shall be deemed to have been duly
       given on the date of service if served personally on the party to whom
       notice is to be given, or on the third (3rd) day after mailing if
       mailed to the party to whom notice is to be given, by first class mail,
       registered or certified, postage prepaid, and properly addressed, or by
       facsimile based on the actual date of the facsimile transmission, as
       follows:

                 ISSUER
                 Aquentium, Inc.
                 Mark Taggatz
                 19125 North Indian Avenue
                 North Palm Springs, CA 92258 USA
                 Facsimile (951) 346-3224

                 TC
                 Theodore Thomas Gerard Ciotti
                 2828 Gulf Gate Drive
                 Sarasota, FL 34231 USA
                 Facsimile (425) 871-8393

IN WITNESS WHEREOF, the undersigned parties have executed this Exclusive
Licensing Agreement on date first indicated above and in the presence of the
respective witnesses.

For Issuer:

/s/ Mark Taggatz                             /s/ Stewart Simpson
_______________________________             _____________________________
Mark Taggatz, President                      Stewart Simpson, Witness
Aquentium, Inc.

Seal of Aquentium, Inc.

For TC:

/s/ Theodore T. Ciotti                       /s/ Joyce Falkowski
_______________________________________     _____________________________
Theodore Thomas Gerard Ciotti, Inventor     Joyce Falkowski, Witness
US Patent Application 10/284,748

                           Page 8 of 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]